Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2016

Open Access 01-12-2016 | Study protocol

The impact of long-lasting microbial larvicides in reducing malaria transmission and clinical malaria incidence: study protocol for a cluster randomized controlled trial

Authors: Guofa Zhou, Virginia Wiseman, Harrysone E. Atieli, Ming-Chieh Lee, Andrew K. Githeko, Guiyun Yan

Published in: Trials | Issue 1/2016

Login to get access

Abstract

Background

The massive scale-up of insecticide-treated nets (ITNs) and indoor residual spraying (IRS) has led to a substantial increase in malaria vector insecticide resistance as well as in increased outdoor transmission, both of which hamper the effectiveness and efficiency of ITN and IRS. Long-lasting microbial larvicide can be a cost-effective new supplemental intervention tool for malaria control.

Methods/design

We will implement the long-lasting microbial larvicide intervention in 28 clusters in two counties in western Kenya. We will test FourStar controlled release larvicide (6 % by weight Bacillus thuringiensis israelensis and 1 % Bacillus sphaerius) by applying FourStar controlled release granule formulation, 90-day briquettes, and 180-day briquettes in different habitat types. The primary endpoint is clinical malaria incidence rate and the secondary endpoint is malaria vector abundance and transmission intensity. The intervention will be conducted as a two-step approach. First, we will conduct a four-cluster trial (two clusters per county, with one of the two clusters randomly assigned to the intervention arm) to optimize the larvicide application scheme. Second, we will conduct an open-label, cluster-randomized trial to evaluate the effectiveness and cost-effectiveness of the larvicide. Fourteen clusters in each county will be assigned to intervention (treatment) or no intervention (control) by a block randomization on the basis of clinical malaria incidence, vector density, and human population size per site. We will treat each treatment cluster with larvicide for three rounds at 4-month intervals, followed by no treatment for the following 8 months. Next, we will switch the control and treatment sites. The former control sites will receive three rounds of larvicide treatment at appropriate time intervals, and former treatment sites will receive no larvicide. We will monitor indoor and outdoor vector abundance using CO2-baited CDC light traps equipped with collection bottle rotators. Clinical malaria data will be aggregated from government-run malaria treatment centers.

Discussion

Since current first-line vector intervention methods do not target outdoor transmission and will select for higher insecticide resistance, new methods beyond bed nets and IRS should be considered. Long-lasting microbial larviciding represents a promising new tool that can target both indoor and outdoor transmission and alleviate the problem of pyrethroid resistance. It also has the potential to diminish costs by reducing larvicide reapplications. If successful, it could revolutionize malaria vector control in Africa, just as long-lasting bed nets have done.

Trial registration

U.S. National Institute of Health, study ID NCT02392832. Registered on 3 February 2015.
Literature
1.
2.
O’Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, Snow RW, et al. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet. 2008;372:1555–62.CrossRefPubMedPubMedCentral
3.
Karema C, Aregawi MW, Rukundo A, Kabayiza A, Mulindahabi M, Fall IS, et al. Trends in malaria cases, hospital admissions and deaths following scale-up of anti-malarial interventions, 2000–2010, Rwanda. Malar J. 2012;11:236.CrossRefPubMedPubMedCentral
4.
Aregawi MW, Ali AS, Al-mafazy AW, Molteni F, Katikiti S, Warsame M, et al. Reductions in malaria and anaemia case and death burden at hospitals following scale-up of malaria control in Zanzibar, 1999-2008. Malar J. 2011;10:46.CrossRefPubMedPubMedCentral
5.
Noor AM, Kinyoki DK, Mundia CW, Kabaria CW, Mutua JW, Alegana VA, et al. The changing risk of Plasmodium falciparum malaria infection in Africa 2000–10: a spatial and temporal analysis of transmission intensity. Lancet. 2014;383:1739–47.CrossRefPubMedPubMedCentral
6.
Trape J-F, Tall A, Sokhna C, Ly AB, Diagne N, Ndiath O, et al. The rise and fall of malaria in a west African rural community, Dielmo, Senegal, from 1990 to 2012: a 22 year longitudinal study. Lancet Infect Dis. 2014;14:476–88.CrossRefPubMed
7.
Coulibaly D, Travassos MA, Kone AK, Tolo Y, Laurens MB, Traore K, et al. Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali. Malar J. 2014;13:374.CrossRefPubMedPubMedCentral
8.
Jagannathan P, Muhindo MK, Kakuru A, Arinaitwe E, Greenhouse B, Tappero J, et al. Increasing incidence of malaria in children despite insecticide-treated bed nets and prompt anti-malarial therapy in Tororo, Uganda. Malar J. 2012;11:435.CrossRefPubMedPubMedCentral
9.
Trape J-F, Tall A, Diagne N, Ndiath O, Ly AB, Faye J, et al. Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect Dis. 2011;11:925–32.CrossRefPubMed
10.
Murhandarwati EE, Fuad A, Nugraheni MD, Sulistyawati, Wijayanti MA, Widartono BS, et al. Early malaria resurgence in pre-elimination areas in Kokap Subdistrict, Kulon Progo, Indonesia. Malar J. 2014;13:130.CrossRefPubMedPubMedCentral
11.
Okiro EA, Bitira D, Mbabazi G, Mpimbaza A, Alegana VA, Talisuna AO, et al. Increasing malaria hospital admissions in Uganda between 1999 and 2009. BMC Med. 2011;9:37.CrossRefPubMedPubMedCentral
12.
Zhou G, Afrane YA, Vardo-Zalik AM, Atieli H, Zhong D, Wamae P, et al. Changing patterns of malaria epidemiology between 2002 and 2010 in Western Kenya: the fall and rise of malaria. PLoS One. 2011;6:e20318.CrossRefPubMedPubMedCentral
13.
Samb B, Dia I, Konate L, Ayala D, Fontenille D, Cohuet A. Population genetic structure of the malaria vector Anopheles funestus, in a recently re-colonized area of the Senegal River basin and human-induced environmental changes. Parasit Vector. 2012;5:188.CrossRef
14.
Kibret S, Wilson GG, Tekie H, Petros B. Increased malaria transmission around irrigation schemes in Ethiopia and the potential of canal water management for malaria vector control. Malar J. 2014;13:360.CrossRefPubMedPubMedCentral
15.
Bayoh MN, Walker ED, Kosgei J, Ombok M, Olang GB, Githeko AK, et al. Persistently high estimates of late night, indoor exposure to malaria vectors despite high coverage of insecticide treated nets. Parasit Vector. 2014;7:380.CrossRef
16.
Ngufor C, Chouaïbou M, Tchicaya E, Loukou B, Kesse N, N’Guessan R, et al. Combining organophosphate-treated wall linings and long-lasting insecticidal nets fails to provide additional control over long-lasting insecticidal nets alone against multiple insecticide-resistant Anopheles gambiae in Côte d’Ivoire: an experimental hut trial. Malar J. 2014;13:396.CrossRefPubMedPubMedCentral
17.
Silva AP, Santos JM, Martins AJ. Mutations in the voltage-gated sodium channel gene of anophelines and their association with resistance to pyrethroids—a review. Parasit Vectors. 2014;7:450.CrossRefPubMedPubMedCentral
18.
Knox TB, Juma EO, Ochomo EO, Pates Jamet H, Ndungo L, Chege P, et al. An online tool for mapping insecticide resistance in major Anopheles vectors of human malaria parasites and review of resistance status for the Afrotropical region. Parasit Vectors. 2014;7:76.CrossRefPubMedPubMedCentral
19.
Coetzee M, Koekemoer LL. Molecular systematics and insecticide resistance in the major African malaria vector Anopheles funestus. Annu Rev Entomol. 2013;58:393–412.CrossRefPubMed
20.
Ranson H, N’guessan R, Lines J, Moiroux N, Nkuni Z, Corbel V. Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control? Trends Parasitol. 2011;27:91–8.CrossRefPubMed
21.
Global Malaria Program WHO. Global plan for insecticide resistance management in malaria vectors. Geneva: WHO; 2012.
22.
Moiroux N, Gomez MB, Pennetier C, Elanga E, Djènontin A, Chandre F, et al. Changes in Anopheles funestus biting behavior following universal coverage of long-lasting insecticidal nets in Benin. J Infect Dis. 2012;206:1622–9.CrossRefPubMed
23.
Reddy MR, Overgaard HJ, Abaga S, Reddy VP, Caccone A, Kiszewski AE, et al. Outdoor host seeking behaviour of Anopheles gambiae mosquitoes following initiation of malaria vector control on Bioko Island, Equatorial Guinea. Malar J. 2011;10:184.CrossRefPubMed
24.
Russell TL, Govella NJ, Azizi S, Drakeley CJ, Kachur SP, Killeen GF. Increased proportions of outdoor feeding among residual malaria vector populations following increased use of insecticide treated nets in rural Tanzania. Malar J. 2012;10:80.CrossRef
25.
Govella NJ, Ferguson H. Why use of interventions targeting outdoor biting mosquitoes will be necessary to achieve malaria elimination. Front Physiol. 2012;3:199.CrossRefPubMedPubMedCentral
26.
Mwangangi JM, Mbogo CM, Orindi BO, Muturi EJ, Midega JT, Nzovu J, et al. Shifts in malaria vector species composition and transmission dynamics along the Kenyan coast over the past 20 years. Malar J. 2013;12:13.CrossRefPubMedPubMedCentral
27.
Stevenson J, St Laurent B, Lobo NF, Cooke MK, Kahindi SC, Oriango RM, et al. Novel vectors of malaria parasites in the western highlands of Kenya. Emerg Infect Dis. 2012;18:1547–9.CrossRefPubMedPubMedCentral
28.
Kitau J, Oxborough RM, Tungu PK, Matowo J, Malima RC, Magesa SM, et al. Species shifts in the Anopheles gambiae complex: do LLINs successfully control Anopheles arabiensis? PLoS One. 2012;7:e31481.CrossRefPubMedPubMedCentral
29.
Killeen GF. Characterizing, controlling and eliminating residual malaria transmission. Malar J. 2014;13:330.
30.
Kitron U, Spielman A. Suppression of transmission of malaria through source reduction: antianopheline measures applied in Israel, the United States, and Italy. Rev Infect Dis. 1989;11:391–406.CrossRefPubMed
31.
32.
Killeen GF, Seyoum A, Knols BG. Rationalizing historical successes of malaria control in Africa in terms of mosquito resource availability management. Am J Trop Med Hyg. 2004;71:87–93.PubMed
33.
Floore TG. Mosquito larval control practices: past and present. J Am Mosq Control Assoc. 2006;22:527–33.
34.
Shililu JI, Tewolde GM, Brantly E, Githure JI, Mbogo CM, Beier JC, et al. Efficacy of Bacillus thuringiensis israelensis, Bacillus sphaericus and temephos for managing Anopheles larvae in Eritrea. J Am Mosq Control Assoc. 2003;19:251–8.PubMed
35.
Fillinger U, Ndenga B, Githeko A, Lindsay SW. Integrated malaria vector control with microbial larvicides and insecticide-treated nets in western Kenya: a controlled trial. Bull World Health Organ. 2009;87:655–65.CrossRefPubMedPubMedCentral
36.
Nartey R, Owusu-Dabo E, Kruppa T, Baffour-Awuah S, Annan A, Oppong S, et al. Use of Bacillus thuringiensis var israelensis as a viable option in an integrated malaria vector control programme in the Kumasi metropolis, Ghana. Parasit Vectors. 2013;6:116.CrossRefPubMedPubMedCentral
37.
Futami K, Kongere JO, Mwania MS, Lutiali PA, Njenga SM, Minakawa N. Effects of Bacillus thuringiensis israelensis on Anopheles arabiensis. J Am Mosq Control Assoc. 2011;27:81–3.CrossRefPubMed
38.
Mwangangi JM, Kahindi SC, Kibe LW, Nzovu JG, Luethy P, Githure JI, et al. Wide-scale application of Bti/Bs biolarvicide in different aquatic habitat types in urban and peri-urban Malindi, Kenya. Parasitol Res. 2011;108:1355–63.CrossRefPubMed
39.
Fillinger U, Lindsay SW. Suppression of exposure to malaria vectors by an order of magnitude using microbial larvicides in rural Kenya. Trop Med Int Health. 2006;11:1629–42.CrossRefPubMed
40.
Geissbühler Y, Kannady K, Chaki PP, Emidi B, Govella NJ, Mayagaya V, et al. Microbial larvicide application by a large-scale, community-based program reduces malaria infection prevalence in urban Dar es Salaam, Tanzania. PLoS One. 2009;4:e5107.CrossRefPubMedPubMedCentral
41.
Mittal PK. Biolarvicides in vector control: challenges and prospects. J Vector Borne Dis. 2003;40:20–32.PubMed
42.
Mbare O, Lindsay SW, Fillinger U. Dose-response tests and semi-field evaluation of lethal and sub-lethal effects of slow release pyriproxyfen granules (SumilarvW0.5G) for the control of the malaria vectors Anopheles gambiae sensu lato. Malar J. 2013;12:94.CrossRefPubMedPubMedCentral
43.
Ndenga B, Githeko A, Omukunda E, Munyekenye G, Atieli H, Wamai P, et al. Population dynamics of malaria vectors in western Kenya highlands. J Med Entomol. 2006;43:200–6.CrossRefPubMed
44.
Zhou G, Afrane YA, Dixit A, Atieli HE, Lee MC, Wanjala CL, et al. Modest additive effects of integrated vector control measures on malaria prevalence and transmission in western Kenya. Malar J. 2013;12:256.CrossRefPubMedPubMedCentral
45.
Ototo EN, Mbugi JP, Wanjala CL, Thumbi SM, Atieli HE, Zhou G, et al. Surveillance of vector population density and biting behavior in Western Kenya. Malar J. 2015. In press.
46.
Lo E, Zhou G, Oo W, Afrane Y, Githeko A, Yan G. Low parasitemia in submicroscopic infections significantly impacts malaria diagnostic sensitivity in the highlands of Western Kenya. PLoS One. 2015;10:e0121763.CrossRefPubMedPubMedCentral
47.
Zhou G, Afrane YA, Malla S, Githeko AK, Yan G. Active case surveillance, passive case surveillance and asymptomatic malaria parasite screening illustrate different age distribution, spatial clustering and seasonality in western Kenya. Malar J. 2015;14:41.CrossRefPubMedPubMedCentral
48.
Zhou G, Li JS, Ototo EN, Atieli HE, Githeko AK, Yan G. Evaluation of universal coverage of insecticide-treated nets in western Kenya: field surveys. Malar J. 2014;13:351.CrossRefPubMedPubMedCentral
49.
Zhou G, Githeko AK, Minakawa N, Yan G. Community-wide benefits of targeted indoor residual spray for malaria control in the western Kenya highland. Malar J. 2010;9:67.CrossRefPubMedPubMedCentral
50.
Lindblade KA, Eisele TP, Gimnig JE, Alaii JA, Odhiambo F, ter Kuile FO, et al. Sustainability of reductions in malaria transmission and infant mortality in western Kenya with use of insecticide-treated bednets: 4 to 6 years of follow-up. JAMA. 2004;291:2571–80.CrossRefPubMed
51.
Atieli HE, Zhou G, Afrane Y, Lee MC, Mwanzo I, Githeko AK, et al. Insecticide-treated net (ITN) ownership, usage, and malaria transmission in the highlands of western Kenya. Parasit Vectors. 2011;4:113.CrossRefPubMedPubMedCentral
52.
Wirtz RA, Ballou WR, Schneider I, Chedid L, Gross MJ, Young JF, et al. Plasmodium falciparum: immunogenicity of circumsporozoite protein constructs produced in Escherichia coli. Exp Parasitol. 1987;63:166–72.CrossRefPubMed
53.
Beier JC, Asiago CM, Onyango FK, Koros JK. ELISA absorbance cut-off method affects malaria sporozoite rate determination in wild Afrotropical Anopheles. Med Vet Entomol. 1988;2:259–64.CrossRefPubMed
54.
Beier JC, Perkins PV, Onyango FK, Gargan TP, Oster CN, Whitmire RE, et al. Characterization of malaria transmission by Anopheles (Diptera: Culicidae) in western Kenya in preparation for malaria vaccine trials. J Med Entomol. 1990;27:570–7.CrossRefPubMed
55.
Kweka EJ, Zhou G, Lee MC, Gilbreath 3rd TM, Mosha F, Munga S, et al. Evaluation of two methods of estimating larval habitat productivity in western Kenya highlands. Parasit Vectors. 2011;4:110.CrossRefPubMedPubMedCentral
56.
Gimnig JE, Kolczak MS, Hightower AW, Vulule JM, Schoute E, Kamau L, et al. Effect of permethrin-treated bed nets on the spatial distribution of malaria vectors in western Kenya. Am J Trop Med Hyg. 2003;68(Suppl):115–20.PubMed
57.
Mulla MS, Norland RL, Fanara DM, Darwazeh A, McKean D. Control of chironomid midges in recreational lakes. J Econom Entomol. 1971;64:300–7.CrossRef
58.
Corbel V, Akogbeto M, Damien GB, Djenontin A, Chandre F, Rogier C, et al. Combination of malaria vector control interventions in pyrethroid resistance area in Benin: a cluster randomised controlled trial. Lancet Infect Dis. 2012;12:617–26.CrossRefPubMed
59.
Hayes RJ, Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol. 1999;28:319–26.CrossRefPubMed
60.
Zöller D, Schmidtmann I, Weinmann A, Gerds TA, Binder H. Stagewise pseudo-value regression for time-varying effects on the cumulative incidence. Statist Med. 2015. doi:10.​1002/​sim.​6770.
61.
Sylvestre MP, Abrahamowicz M. Flexible modeling of the cumulative effects of time-dependent exposures on the hazard. Statist Med. 2009;28:3437–53.CrossRef
62.
Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford, New York: Oxford University Press; 2005.
63.
64.
Caquet T, Roucaute M, Le Goff P, Lagadic L. Effects of repeated field applications of two formulations of Bacillus thuringiensis var. israelensis on non-target saltmarsh invertebrates in Atlantic coastal wetlands. Ecotoxicol Environ Saf. 2011;74:1122–30.CrossRefPubMed
65.
The malERA Consultative Group on Vector Control. A research agenda for malaria eradication: vector control. PLoS Med. 2011;8:e1000401.
66.
Walker K, Lynch M. Contributions of Anopheles larval control to malaria suppression in tropical Africa: review of achievements and potential. Med Vet Entomol. 2007;21:2–21.CrossRefPubMed
67.
Boonserm P, Ellar DJ, Li J. Crystallization and preliminary X-ray diffraction studies of a mosquito-larvicidal toxin from Bacillus thuringiensis subsp. israelensis. Acta Crystallogr D Biol Crystallogr. 2003;59(Pt 3):591–4.CrossRefPubMed
68.
Kweka EJ, Zhou G, Munga S, Lee MC, Atieli HE, Nyindo M, et al. Anopheline larval habitats seasonality and species distribution: a prerequisite for effective targeted larval habitats control programmes. PLoS One. 2012;7:e52084.CrossRefPubMedPubMedCentral
69.
Himeidan YE, Zhou G, Yakob L, Afrane Y, Munga S, Atieli H, et al. Habitat stability and occurrences of malaria vector larvae in western Kenya highlands. Malar J. 2009;8:234.CrossRefPubMedPubMedCentral
70.
Munga S, Minakawa N, Zhou G, Githeko AK, Yan G. Survivorship of immature stages of Anopheles gambiae s.l. (Diptera: Culicidae) in natural habitats in western Kenya highlands. J Med Entomol. 2007;44:758–64.CrossRefPubMed
71.
Minakawa N, Omukunda E, Zhou G, Githeko A, Yan G. Malaria vector productivity in relation to the highland environment in Kenya. Am J Trop Med Hyg. 2006;75:448–53.PubMed
72.
Metadata
Title
The impact of long-lasting microbial larvicides in reducing malaria transmission and clinical malaria incidence: study protocol for a cluster randomized controlled trial
Authors
Guofa Zhou
Virginia Wiseman
Harrysone E. Atieli
Ming-Chieh Lee
Andrew K. Githeko
Guiyun Yan
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Trials / Issue 1/2016
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-016-1545-4

Other articles of this Issue 1/2016

Trials 1/2016 Go to the issue

Study protocol

The effectiveness of the peer delivered Thinking Healthy Plus (THPP+) Programme for maternal depression and child socio-emotional development in Pakistan: study protocol for a three-year cluster randomized controlled trial

Study protocol

PRONTOX – proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial

Study protocol

The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial

Erratum

Erratum to: ‘Recruitment challenges in clinical research including cancer patients and their caregivers. A randomized controlled trial study and lessons learned’

Research

A qualitative exploration of trial-related terminology in a study involving Deaf British Sign Language users

Study protocol

Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trial